Detailed Information
Cited 1 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
waveLINE-006: A phase 2 study of the safety and efficacy of zilovertamab vedotin as monotherapy or in combination in patients (pts) with aggressive and indolent B-cell malignancies.
- Authors
- Zinzani, PL[Zinzani, Pier Luigi]; Mayer, J[Mayer, Jiri]; Benjamini, O[Benjamini, Ohad]; Berkovits, A[Berkovits, Alejandro]; Glimelius, I[Glimelius, Ingrid]; Stevens, DA[Stevens, Don A.]; Chaudhry, A[Chaudhry, Arvind]; Demir, AM[Demir, Ahmet Muzaffer]; Sanz, RG[Sanz, Ramon Garcia]; Kim, WS[Kim, Won Seog]; Li, F[Li, Fei]; Halka, J[Halka, Janusz]; Marin-Niebla, A[Marin-Niebla, Ana]; Ozcan, M[Ozcan, Muhit]; Paszkiewicz-Kozik, E[Paszkiewicz-Kozik, Ewa]; Santoro, A[Santoro, Armando]; Ren, YX[Ren, Yixin]; Ogbu, U[Ogbu, Uzor]; Marinello, P[Marinello, Patricia]; Jurczak, W[Jurczak, Wojciech]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.